COMMUNIQUÉS West-GlobeNewswire

Radius Health Announces Five Presentations on elacestrant (RAD1901) at the San Antonio Breast Cancer Symposium (SABCS)
04/12/2017
SABCS to include five abstracts from the development program for elacestrant as a potential treatment of ER-positive advanced breast cancer Radius to host live webcast to discuss data presented at SABCS and provide a [...]
La Jolla Pharmaceutical Company Announces Initiation of Pivotal Clinical Study of LJPC‑401 in Patients with Beta Thalassemia
04/12/2017
SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (NASDAQ: LJPC ) (the Company or La Jolla) today announced the initiation of a pivotal clinical study of LJPC‑401 (synthetic human hepcidin) in [...]
Teladoc Adds New Health System Clients, Achieving 2017 Growth in Excess of 100%
04/12/2017
PURCHASE, NY, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ) the world’s largest and most trusted provider of virtual care delivery services, today announced record growth of greater than 100% in the [...]
Marrone Bio Innovations Adds Three Commercial Managers for Southeast, West Coast, and Northeast and Mid-Atlantic Regions
04/12/2017
DAVIS, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental [...]
Novelion Therapeutics Appoints Michael Price as Senior Vice President and Chief Financial Officer
04/12/2017
VANCOUVER, British Columbia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T Therapies
04/12/2017
NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
FDA Selects HemoStyp® for CtQ Pilot Program
04/12/2017
HENDERSON, Nev., Dec. 04, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]
Uptick Newswire “Stock Day” Interviews CEO of Progressive Care on the Completed Success in the Pharmaceutical Industry
04/12/2017
Miami, FL , Dec. 04, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire “Stock Day” host Everett Jolly warmly welcomes back a long awaited guest Shital Mars, CEO of Progressive Care Inc. (OTCPink: RXMD) (“Progressive Care” or the [...]
Canadian Blood Services board meeting open to the public
04/12/2017
OTTAWA, Dec. 04, 2017 (GLOBE NEWSWIRE) -- On Dec. 7, Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at blood.ca, and inviting the public to attend in [...]
La réunion du conseil d’administration de la Société canadienne du sang ouverte au public
04/12/2017
OTTAWA, 04 déc. 2017 (GLOBE NEWSWIRE) -- La Société canadienne du sang invite la population à assister, en personne ou en ligne, à la réunion de son conseil d’administration. La réunion aura lieu le 7 décembre à Ottawa [...]
CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel
04/12/2017
NEWARK, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel
04/12/2017
NEWARK, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
VANC Pharmaceuticals Executes Share Purchase Agreement to Acquire HealthTab Inc.
04/12/2017
VANCOUVER, British Columbia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“ VANC ” or the “ Company ”) (TSXV:VANC) (OTCQB:NUVPF) is pleased to announce that it has entered into a share purchase agreement [...]
CorVel Successfully Implements CareMC Edge
04/12/2017
IRVINE, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL ) announced today the successful implementation of their CareMC Edge data integration tool for the insurance carrier marketplace. [...]
The American Health Council Physician Board Welcomes Indrani Hightower, MD
04/12/2017
NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to recognize Indrani Sen Hightower, MD as an affiliate of its Physician Board. She has spent the last two years as a Neurologist at [...]
XBiotech Announces Publication of Phase 2 Data from Hidradenitis Suppurativa Phase 2 Study in The Journal of Investigative Dermatology
04/12/2017
AUSTIN, Texas, Dec. 04, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today the publication of data from its randomized phase 2 study evaluating XBiotech’s True Human™ antibody, MABp1, as a treatment [...]
Emblem Corp. Provides Business Update for 2018
04/12/2017
TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. ( “Emblem” or the “ Company ”) (TSXV:EMC), a vertically integrated cannabis company focused on research, development, production and distribution of cannabis [...]
Daré Bioscience, Inc. to Present at the LD Micro 10th Annual Main Event Conference
04/12/2017
SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a healthcare company committed to the development and commercialization of innovative products in women’s reproductive health, today [...]
Zogenix Announces New Positive Efficacy and Safety Data from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
04/12/2017
ZX008 Patients More Likely to Achieve Clinically Meaningful Reduction in Seizure Frequency Compared to Those on Placebo Parents/Caregivers and Investigators Rated Patients Treated with ZX008 as Very Much Improved or [...]

Pages